1. The molecular mechanisms of chemoresistance in cancers
   Hua-Chuan Zheng, 2017, Oncotarget CrossRef
2. Proscillaridin A Promotes Oxidative Stress and ER Stress, Inhibits STAT3 Activation, and Induces Apoptosis in A549 Lung Adenocarcinoma Cells
   Amara Maryam et al, 2018, Oxidative Medicine and Cellular Longevity CrossRef
3. Glutathione S-Transferases in Cancer
   Rahul Raj Singh et al, 2021, Antioxidants CrossRef
4. Mechanisms of multidrug resistance in cancer
   Fatemeh Zahedipour et al, 2023, Aptamers Engineered Nanocarriers for Cancer Therapy CrossRef
5. Rethink of EGFR in Cancer With Its Kinase Independent Function on Board
   Rintu Thomas et al, 2019, Frontiers in Oncology CrossRef
6. Reciprocal regulation of miR‐206 and IL‐6/STAT3 pathway mediates IL6‐induced gefitinib resistance in EGFR‐mutant lung cancer cells
   Yanhua Yang et al, 2019, Journal of Cellular and Molecular Medicine CrossRef
7. Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by increased sensitivity to STAT3 inhibition
   NIKOLAOS IOANNOU et al, 2016, International Journal of Oncology CrossRef
8. Gefitinib induces non‑small cell lung cancer H1650 cell apoptosis through downregulating tumor necrosis factor‑related apoptosis‑inducing ligand expression levels
   Hanjie Yi et al, 2018, Oncology Letters CrossRef
9. Adaptive EGF expression sensitizes pancreatic cancer cells to ionizing radiation through activation of the cyclin D1/P53/PARP pathway
   Xiaoxing Liu et al, 2019, International Journal of Oncology CrossRef
10. Alantolactone induces apoptosis, promotes STAT3 glutathionylation and enhances chemosensitivity of A549 lung adenocarcinoma cells to doxorubicin via oxidative stress
    Amara Maryam et al, 2017, Scientific Reports CrossRef
11. Exploration of Pd-catalysed four-component tandem reaction for one-pot assembly of pyrazolo[1,5-c]quinazolines as potential EGFR inhibitors
    Arshad J. Ansari et al, 2019, Bioorganic Chemistry CrossRef
12. A rotamer relay information system in the epidermal growth factor receptor–drug complexes reveals clues to new paradigm in protein conformational change
    Tareq Hameduh et al, 2021, Computational and Structural Biotechnology Journal CrossRef
13. Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Transducer and Activator of Transcription and Epidermal Growth Factor Receptor Inhibition
    Timothy J. Stuhlmiller et al, 2017, Journal of the American Heart Association CrossRef
14. Continuous targeted kinase inhibitors treatment induces upregulation of PD-L1 in resistant NSCLC
    Li Jiang et al, 2019, Scientific Reports CrossRef
15. In vitro cell culture of patient derived malignant pleural and peritoneal effusions for personalised drug screening
    Cheng-Guang Wu et al, 2020, Journal of Translational Medicine CrossRef
16. Development of Erasin: a chromone-based STAT3 inhibitor which induces apoptosis in Erlotinib-resistant lung cancer cells
    Christian Lis et al, 2017, Scientific Reports CrossRef
17. Phenolic diterpenes from Rosemary supercritical extract inhibit non-small cell lung cancer lipid metabolism and synergise with therapeutic drugs in the clinic
    Adrián Bouzas et al, 2022, Frontiers in Oncology CrossRef